The TCGA database shows that the SETDB1 gene is amplified in many tumours, such as liver cancer, bladder cancer, breast cancer, uterine cancer and melanomas, and in ovarian cancer, 7.4% of the SETDB1 gene is amplified [50, 51]. This evidence concerns the gene SETDB1 and melanoma.